Literature DB >> 2725521

Human retinoblastoma gene: long-range mapping and analysis of its deletion in a breast cancer cell line.

R Bookstein1, E Y Lee, A Peccei, W H Lee.   

Abstract

Mutational inactivation of the retinoblastoma (RB) gene is considered a fundamental event in the formation of several types of human cancer. A substantial proportion of RB gene mutations are partial or complete deletions that extend an unknown distance beyond one or both ends of the gene. To provide a framework for measuring the extent of these deletions, we have constructed a long-range restriction map of SfiI sites spanning 850 kilobases around the RB gene. This map was applied in a molecular analysis of RB gene deletion in breast cancer cell line MB468. A previous study of this cell line demonstrated deletion of the entire RB gene except for exons 1 and 2 (E. Y.-H. P. Lee, H. To, J.-Y. Shew, R. Bookstein, P. Scully, and W.-H. Lee, Science 241:218-221, 1988). Genomic clones containing the deletion junction were isolated from a library made from MB468 DNA. A probe obtained from the far side of the deletion junction was used to localize and clone the unknown 3' endpoint, demonstrating that the chromosomal mutation in this case was a simple deletion spanning 200 kilobases. Sequence analysis of the deletion junction indicated a conservative deletion with no loss or gain of nucleotides. The deletion endpoints had no sequence homology to each other or to any repetitive sequence family, such as Alu, so the recombination event was illegitimate. Structural analysis of this and other RB gene deletions is important for understanding molecular mechanisms of recessive oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725521      PMCID: PMC362580          DOI: 10.1128/mcb.9.4.1628-1634.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.

Authors:  J Toguchida; K Ishizaki; M S Sasaki; M Ikenaga; M Sugimoto; Y Kotoura; T Yamamuro
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

2.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

3.  Unexpected relationships between four large deletions in the human beta-globin gene cluster.

Authors:  E F Vanin; P S Henthorn; D Kioussis; F Grosveld; O Smithies
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein.

Authors:  S H Friend; J M Horowitz; M R Gerber; X F Wang; E Bogenmann; F P Li; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  A case of synovial sarcoma with abnormal expression of the human retinoblastoma susceptibility gene.

Authors:  A E Mendoza; J Y Shew; E Y Lee; R Bookstein; W H Lee
Journal:  Hum Pathol       Date:  1988-04       Impact factor: 3.466

8.  Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants.

Authors:  R Bookstein; E Y Lee; H To; L J Young; T W Sery; R C Hayes; T Friedmann; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors.

Authors:  A D Goddard; H Balakier; M Canton; J Dunn; J Squire; E Reyes; A Becker; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

10.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers.

Authors:  E Y Lee; H To; J Y Shew; R Bookstein; P Scully; W H Lee
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

View more
  9 in total

1.  A novel, plasmid-based system for studying gene rearrangements in mammalian cells.

Authors:  R S Krauss; I B Weinstein
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

2.  Molecular analysis of two mouse dilute locus deletion mutations: spontaneous dilute lethal20J and radiation-induced dilute prenatal lethal Aa2 alleles.

Authors:  M C Strobel; P K Seperack; N G Copeland; N A Jenkins
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

3.  Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events.

Authors:  M Laiho; L Rönnstrand; J Heino; J A Decaprio; J W Ludlow; D M Livingston; J Massagué
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

5.  Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Authors:  Zhe Jiang; Tao Deng; Robert Jones; Huiqin Li; Jason I Herschkowitz; Jeff C Liu; Victor J Weigman; Ming-Sound Tsao; Timothy F Lane; Charles M Perou; Eldad Zacksenhaus
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

6.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.

Authors:  J Y Shew; B T Lin; P L Chen; B Y Tseng; T L Yang-Feng; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Parental origin of germ-line and somatic mutations in the retinoblastoma gene.

Authors:  M V Kato; K Ishizaki; T Shimizu; Y Ejima; H Tanooka; J Takayama; A Kaneko; J Toguchida; M S Sasaki
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

8.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.

Authors:  B T Lin; S Gruenwald; A O Morla; W H Lee; J Y Wang
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

9.  RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs.

Authors:  Tyler J W Robinson; Jeff C Liu; Frederick Vizeacoumar; Thomas Sun; Neil Maclean; Sean E Egan; Aaron D Schimmer; Alessandro Datti; Eldad Zacksenhaus
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.